Reata Pharmaceuticals

15 email addresses found for reatapharma.com
{first}-{last}@reatapharma.com
15 email addresses
http://biospace.com/article/releases/reata-announces-improvements-in-kidney-function-with-bardoxolone-methyl-maintained-for-two-years-in-pah-patients-from-lariat-trial September 9, 2018
http://biospace.com/article/releases/reata-pharmaceuticals-inc-s-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-in-ongoing-phase-ii-portion-of October 10, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-pricing-of/464426 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-s-bardoxolone-methyl/463868 September 9, 2017
http://cnbc.com/2016/05/25/globe-newswire-reata-pharmaceuticals-inc-announces-pricing-of-initial-public-offering.html February 2, 2018
http://cnbc.com/2016/06/01/globe-newswire-reata-pharmaceuticals-inc-announces-closing-of-initial-public-offering-including-full-exercise-of-underwritersa-option-to.html August 8, 2018
http://cnbc.com/2016/11/14/globe-newswire-reata-pharmaceuticals-inc-announces-third-quarter-2016-financial-and-operating-results.html September 9, 2018
http://cnbc.com/2017/03/03/globe-newswire-reata-pharmaceuticals-inc-announces-fourth-quarter-and-full-year-2016-financial-and-operating-results.html September 9, 2018
http://cnbc.com/2017/08/01/globe-newswire-reata-pharmaceuticals-inc-announces-closing-of-class-a-common-stock-public-offering-and-full-exercise-of-underwritersa.html November 11, 2017
http://crweworld.com/article/news-provided-by-globenewswire/137598/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma October 10, 2017
http://euroinvestor.com/news/2017/09/13/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/13672330 November 11, 2017
http://firstwordpharma.com/node/1504861 October 10, 2017
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://globenewswire.com/news-release/2017/06/22/1027609/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-friedreich-s-ataxia.html October 10, 2018
http://health.einnews.com/pr_news/403741941/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma October 10, 2017
http://investors.reatapharma.com September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-late-breaking-presentation-primary-results-phase September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-closing-class-common-stock September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-third-quarter-2016-financial September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-scheduled-attend-upcoming-investor-conferences September 9, 2018
http://markets.businessinsider.com/news/stocks/reata-pharmaceuticals-inc-announces-third-quarter-2017-financial-and-operating-results-1007869226 September 9, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-announces-positive-phase-2-data-bardoxolone-methyl-ckd October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-closing-class-common-stock-0 October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-proposed-public-offering-0 October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-report-second-quarter-2018-financial October 10, 2018
http://news.reatapharma.com/shareholder-services/contact-ir October 10, 2018
http://thenewsreports.com/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/32035/staff October 10, 2017
http://united795.rssing.com/chan-13731600/all_p1066.html September 9, 2018
http://united795.rssing.com/chan-13731600/all_p1117.html September 9, 2018
http://biospace.com/article/releases/reata-announces-improvements-in-kidney-function-with-bardoxolone-methyl-maintained-for-two-years-in-pah-patients-from-lariat-trial September 9, 2018
http://biospace.com/article/releases/reata-pharmaceuticals-inc-s-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-in-ongoing-phase-ii-portion-of September 9, 2018
http://cnbc.com/2016/05/25/globe-newswire-reata-pharmaceuticals-inc-announces-pricing-of-initial-public-offering.html September 9, 2018
http://cnbc.com/2016/06/01/globe-newswire-reata-pharmaceuticals-inc-announces-closing-of-initial-public-offering-including-full-exercise-of-underwritersa-option-to.html August 8, 2018
http://cnbc.com/2016/11/14/globe-newswire-reata-pharmaceuticals-inc-announces-third-quarter-2016-financial-and-operating-results.html September 9, 2018
http://cnbc.com/2017/03/03/globe-newswire-reata-pharmaceuticals-inc-announces-fourth-quarter-and-full-year-2016-financial-and-operating-results.html September 9, 2018
http://cnbc.com/2017/08/01/globe-newswire-reata-pharmaceuticals-inc-announces-closing-of-class-a-common-stock-public-offering-and-full-exercise-of-underwritersa.html September 9, 2018
http://crweworld.com/article/news-provided-by-globenewswire/137598/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma September 9, 2018
http://euroinvestor.com/news/2017/09/13/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/13672330 September 9, 2018
http://firstwordpharma.com/node/1504861 October 10, 2017
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://globenewswire.com/news-release/2017/06/22/1027609/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-friedreich-s-ataxia.html October 10, 2018
http://health.einnews.com/pr_news/403741941/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma August 8, 2018
http://investors.reatapharma.com/news-releases/news-release-details/company-statement-termination-beacon-trial September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-late-breaking-presentation-primary-results-phase September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-closing-class-common-stock September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-third-quarter-2016-financial September 9, 2018
http://investors.reatapharma.com/news-releases/news-release-details/reata-scheduled-attend-upcoming-investor-conferences September 9, 2018
http://markets.businessinsider.com/news/stocks/reata-pharmaceuticals-inc-announces-third-quarter-2017-financial-and-operating-results-1007869226 September 9, 2018
http://marketwired.com/press-release/reata-enrolls-first-patient-with-pulmonary-hypertension-associated-with-interstitial-2085474.htm September 9, 2018
http://mitoaction.org/blog/2016-mito-town-meeting September 9, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-announces-positive-phase-2-data-bardoxolone-methyl-ckd October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-closing-class-common-stock-0 October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-proposed-public-offering-0 October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-announces-second-quarter-2018 October 10, 2018
http://news.reatapharma.com/news-releases/news-release-details/reata-pharmaceuticals-inc-report-second-quarter-2018-financial October 10, 2018
http://thenewsreports.com/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/32035/staff September 9, 2018
http://united795.rssing.com/chan-13731600/all_p1066.html September 9, 2018
http://united795.rssing.com/chan-13731600/all_p1117.html September 9, 2018
Show more results
5 more results for reatapharma.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about reatapharma.com

Language of the website: English